Clinical trialNCT07080242RecruitingPhase 1Interventional

Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors

SponsorSystImmune Inc.Enrollment120Locally Advanced Extrapulmonary Neuroendocrine CarcinomaLocally Advanced Large Cell Neuroendocrine Carcinoma of the LungLocally Advanced Merkel Cell CarcinomaLocally Advanced Neuroendocrine Prostate CancerLocally Advanced Poorly Differentiated Gastroenteropancreatic NeuroendocrineMetastatic Advanced Merkel Cell Carcinoma+5 more conditions

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Rishi Jain
SystImmune Inc.
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

20 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Clearview Cancer Institute
Huntsville, Alabama, United States
Jorge Diaz, MD
Not, yet, recruiting
Ucla
Los Angeles, California, United States
Joel Hecht, MD
Not, yet, recruiting
Valkyrie Clinical Trials
Los Angeles, California, United States
David Berz, MD, PhD, MPH
Recruiting
Ucsf- San Francisco (helen Diller Family Comprehensive Cancer Center)
San Francisco, California, United States
Rahul Aggarwal, MD
Not, yet, recruiting
University of Colorado - Anschutz Cancer Pavilion
Aurora, Colorado, United States
Tejas Patil, MD
Not, yet, recruiting
Yale Cancer Center
New Haven, Connecticut, United States
Pamela Kunz, MD
Recruiting
Emory Winship
Atlanta, Georgia, United States
Olatunji Alese, MD
Recruiting
John Theurer Cancer Center-Hackensack
Hackensack, New Jersey, United States
Martin Gutierrez, MD
Recruiting
Rutgers Cancer Institute
New Brunswick, New Jersey, United States
Sanjay Goel, MD
Recruiting
Icahn School of Medicine at Mount Sinai
New York, New York, United States
Deborah Doroshow, MD
Recruiting
Ohio State University
Columbus, Ohio, United States
Bhavana Konda, MD
Recruiting
Providence Cancer Institute
Portland, Oregon, United States
Rachel Sanborn, MD
Recruiting
Prisma Health Cancer Institute
Greenville, South Carolina, United States
Jeffrey Edenfield, MD
Recruiting
Next Dallas
Dallas, Texas, United States
Michael Song, MD, PhD, PharmD
Recruiting
Start Dallas- Fort Worth
Dallas, Texas, United States
Henry Xiong, MD
Recruiting
Md Anderson Cancer Center
Houston, Texas, United States
Timothy Yap, MD
Recruiting
Next Houston
Houston, Texas, United States
Jennifer Segar, MD
Recruiting
Start- San Antonio
San Antonio, Texas, United States
Drew Rasco, MD
Recruiting
Next Oncology Virginia
Fairfax, Virginia, United States
Alexander Spira
Recruiting
University of Washington/fred Hutchinson Cancer Center
Seattle, Washington, United States
Shailender Bhatia, MD
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

BL-M14D1 →

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 28 Apr 2025
Primary completion: 31 Dec 2027
Completion: 31 Dec 2027
Last update posted: 22 May 2026
Registered enrollment: 120
Registry id: NCT07080242

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.